Clinical Stage BioOmeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system.
Total money raised: $63M
Omeros at CrunchBase
Stock symbol: OMER
Omeros raised $63M in a Series E round from Aravis Ventures, ARCH Venture Partners, The Grosvenor Funds, Novartis Venture Fund, Southern Cross Venture Partners, Stanley Medical Research Institute, Trevi Health Ventures, and WRF Capital